Montelukast in guidelines and beyond

Advances in Therapy

Volumn 26, Issue 6, 2009, Pages 575-587

  Bousquet, Jean ^a,b   Demoly, Pascal ^a,c   Humbert, Marc ^d  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b INSERM   (France)

^c INSERM U657   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Allergic rhinitis; Asthma; Guidelines; Inhaled corticosteroids; Montelukast; Rhinitis

Indexed keywords

ACETYLSALICYLIC ACID; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; FLUTICASONE; GLUCOCORTICOID; LORATADINE; MONTELUKAST; PLACEBO; SALMETEROL; ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; QUINOLINE DERIVATIVE;

ADD ON THERAPY; AIRWAY OBSTRUCTION; ASTHMA; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; EVENING DOSAGE; EXERCISE; HEALTH CARE UTILIZATION; HUMAN; LOW DRUG DOSE; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; PATIENT COMPLIANCE; PERENNIAL RHINITIS; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; REVIEW; RHINITIS; SMOKING; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; HAY FEVER;

ACETATES; ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS; LEUKOTRIENE ANTAGONISTS; PRACTICE GUIDELINES AS TOPIC; QUINOLINES; RHINITIS, ALLERGIC, SEASONAL;

EID: 73349101119     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0038-1     Document Type: Review

References (73)

1. J. Bousquet 2000 Global Initiative for Asthma (GINA) and its objectives Clin Exp Allergy 30 suppl.1 2 5 10.1046/j.1365-2222.2000.00088.x 10849466
2. J. Bousquet T. Bieber W. Fokkens 2008 Consensus statements, evidence-based medicine and guidelines in allergic diseases Allergy 63 1 4 1:STN:280:DC%2BD2sjisVCksg%3D%3D 18053012
3. J. Bousquet T.J. Clark S. Hurd 2007 GINA guidelines on asthma and beyond Allergy 62 102 112 1:STN:280:DC%2BD2s%2FpvFKjsw%3D%3D 17298416
4. E.D. Bateman S.S. Hurd P.J. Barnes 2008 Global strategy for asthma management and prevention: GINA executive summary Eur Respir J 31 143 178 10.1183/09031936.00138707 1:CAS:528:DC%2BD1cXhvVCgsL8%3D 18166595
5. W.W. Busse R.F. Lemanske Jr 2007 Expert Panel Report 3: Moving forward to improve asthma care J Allergy Clin Immunol 120 1012 1014 10.1016/j.jaci.2007. 09.016 17983868 (Pubitemid 350029915)
6. British Thoracic Society Scottish Intercollegiate Guidelines Network. 2008 British Guideline on the Management of Asthma Thorax 63 suppl.4 iv1 iv121 10.1136/thx.2008.097741 (Pubitemid 351692371)
7. M. Humbert S. Holgate L.P. Boulet J. Bousquet 2007 Asthma control or severity: that is the question Allergy 62 95 101 1:STN:280: DC%2BD2s%2FpvFKjsg%3D%3D 17298415
8. S. Accordini A. Corsico I. Cerveri 2008 The socioeconomic burden of asthma is substantial in Europe Allergy 63 116 124 1:STN:280: DC%2BD2sjisVCkuw%3D%3D 18053021
9. J.D. Campbell D.E. Spackman S.D. Sullivan 2008 Health economics of asthma: assessing the value of asthma interventions Allergy 63 1581 1592 10.1111/j.1398-9995.2008.01888.x 1:STN:280:DC%2BD1cjmsV2juw%3D%3D 19032230
10. C. van Weel 2008 General practitioners' central role in management of asthma and allergic rhinitis Allergy 63 1005 1007 10.1111/j.1398-9995.2008. 01655.x 18691303
11. K. Herland J.P. Akselsen O.H. Skjonsberg L. Bjermer 2005 How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med 99 11 19 10.1016/j.rmed.2004.03.026 15672843 (Pubitemid 40017378)
12. R. Tomlins 2006 International Primary Care Respiratory Group (IPCRG) Guidelines: Dissemination and Implementation - a proposed course of action Prim Care Respir J 15 71 74 10.1016/j.pcrj.2005.11.004 16701760 (Pubitemid 43155768)
13. J. Bousquet J. Reid C. van Weel 2008 Allergic rhinitis management pocket reference 2008 Allergy 63 990 996 10.1111/j.1398-9995.2008.01642.x 1:STN:280:DC%2BD1crgvFGnug%3D%3D 18691301
14. C. van Weel E.D. Bateman J. Bousquet 2008 Asthma management pocket reference 2008 Allergy 63 997 1004 10.1111/j.1398-9995.2008.01643.x 18691302
15. J. Bousquet P. Van Cauwenberge N. Khaltaev 2001 Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 108 S147 S334 10.1067/mai.2001.118891 1:STN:280:DC%2BD3MnlsVKktA%3D%3D 11707753
16. J. Bousquet N. Khaltaev A.A. Cruz 2008 Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) Allergy 63 suppl.86 8 160 10.1111/j.1398-9995.2007.01620.x 18331513 (Pubitemid 351357811)
17. J.C. Virchow Jr. A. Prasse I. Naya L. Summerton A. Harris 2000 Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids Am J Respir Crit Care Med 162 578 585 10934090
18. P.B. Watkins L.M. Dube K. Walton-Bowen C.M. Cameron L.E. Kasten 2007 Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma Drug Saf 30 805 815 10.2165/00002018- 200730090-00006 1:CAS:528:DC%2BD2sXht1amsb%2FJ 17722971 (Pubitemid 47347353)
19. NAEPP (National Asthma Education and Prevention Program) Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Heart Lung and Blood Institute. Available at: http://www.nhlbi.nih.gov/guidelines/ asthma/index.htm. Accessed May 2007.
20. S.P. Peters N. Anthonisen M. Castro 2007 N Engl J Med 356 2027 2039 10.1056/NEJMoa070013 17507702 (Pubitemid 46789893)
21. M.J. Vaquerizo P. Casan J. Castillo 2003 Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma Thorax 58 204 210 10.1136/thorax.58.3.204 1:STN:280:DC%2BD3s7hs1GgtA%3D%3D 12612294 (Pubitemid 36307997)
22. C.G. Lofdahl T.F. Reiss J.A. Leff 1999 Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients BMJ 319 87 90 1:CAS:528: DyaK1MXltVWhsro%3D 10398629
23. I. Baiardini F. Braido S. Brandi 2008 The impact of GINA suggested drugs for the treatment of asthma on health-related quality of life: a GA(2)LEN review Allergy 63 1015 1030 10.1111/j.1398-9995.2008.01823.x 1:STN:280: DC%2BD1crgvFGmsA%3D%3D 18691305
24. P. Montuschi C. Mondino P. Koch G. Ciabattoni P.J. Barnes G. Baviera 2007 Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma Chest 132 1876 1881 10.1378/chest.07-1587 1:CAS:528:DC%2BD1cXhtlSjt74%3D 18079221
25. L. Jayaram M. Duong M.M. Pizzichini 2005 Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma Eur Respir J 25 41 46 10.1183/09031936.04.00008104 1:CAS:528:DC%2BD2MXhtFGhsrw%3D 15640321 (Pubitemid 40207729)
26. L. Bjermer H. Bisgaard J. Bousquet 2003 Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial BMJ 327 891 10.1136/bmj.327.7420.891 1:CAS:528:DC%2BD3sXptlCis70%3D 14563743
27. Ducharme FM, Lasserson TJ, Cates CJ. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev. 2006;(4):CD003137.
28. S. Joos A. Miksch J. Szecsenyi 2008 Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review Thorax 63 453 462 10.1136/thx.2007.081596 1:STN:280: DC%2BD1c3otFWiuw%3D%3D 18443162 (Pubitemid 351698876)
29. A. Deykin M.E. Wechsler H.A. Boushey 2007 Combination therapy with a long-acting beta-agonist and a leukotriene antagonist in moderate asthma Am J Respir Crit Care Med 175 228 234 10.1164/rccm.200601-112OC 1:CAS:528: DC%2BD2sXivF2kur8%3D 16973987 (Pubitemid 46203125)
30. D.S. Robinson D. Campbell P.J. Barnes 2001 Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial Lancet 357 2007 2011 10.1016/S0140-6736(00)05113-8 1:CAS:528:DC%2BD3MXks1Oisb0%3D 11438132 (Pubitemid 32592387)
31. R.A. Baumgartner G. Martinez J.M. Edelman 2003 Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone Eur Respir J 21 123 128 10.1183/09031936.03.00028803 1:CAS:528:DC%2BD3sXhsFagsr8%3D 12570120 (Pubitemid 36150312)
32. J.D. Spahn R.A. Covar N. Jain 2006 Effect of montelukast on peripheral airflow obstruction in children with asthma Ann Allergy Asthma Immunol 96 541 549 1:CAS:528:DC%2BD28Xks1Cisbs%3D 16680924
33. M.R. Zeidler E.C. Kleerup J.G. Goldin 2006 Montelukast improves regional air-trapping due to small airways obstruction in asthma Eur Respir J 27 307 315 10.1183/09031936.06.00005605 1:CAS:528:DC%2BD28Xhslansbw%3D 16452585 (Pubitemid 43180907)
34. S.C. Lazarus V.M. Chinchilli N.J. Rollings 2007 Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma Am J Respir Crit Care Med 175 783 790 10.1164/rccm.200511-1746OC 1:CAS:528: DC%2BD2sXltlOnurc%3D 17204725 (Pubitemid 46631789)
35. N. Rabinovitch M. Strand K. Stuhlman E.W. Gelfand 2008 Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast J Allergy Clin Immunol 121 1365 1371 10.1016/j.jaci.2008.03.016 1:CAS:528:DC%2BD1cXmvV2ktb8%3D 18439662
36. M. Peters-Golden A. Swern S.S. Bird C.M. Hustad E. Grant J.M. Edelman 2006 Influence of body mass index on the response to asthma controller agents Eur Respir J 27 495 503 10.1183/09031936.06.00077205 1:CAS:528: DC%2BD28XjtVKqtLc%3D 16507848 (Pubitemid 43372522)
37. S.E. Dahlen K. Malmstrom E. Nizankowska 2002 Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial Am J Respir Crit Care Med 165 9 14 11779723
38. J.A. Leff W.W. Busse D. Pearlman 1998 Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction N Engl J Med 339 147 152 10.1056/NEJM199807163390302 1:CAS:528:DyaK1cXkvFGhsbc%3D 9664090 (Pubitemid 28328478)
39. C. Rand A. Bilderback K. Schiller J.M. Edelman C.M. Hustad R.S. Zeiger 2007 Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial J Allergy Clin Immunol 119 916 923 10.1016/j.jaci.2006.12.664 1:CAS:528: DC%2BD2sXjvFaksLc%3D 17349681 (Pubitemid 46546427)
40. N. Barnes M. Thomas D. Price H. Tate 2005 The national montelukast survey J Allergy Clin Immunol 115 47 54 10.1016/j.jaci.2004.10.011 15637546 (Pubitemid 40075420)
41. L.B. Bacharier A. Boner K.H. Carlsen 2008 Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report Allergy 63 5 34 10.1111/j.1398-9995.2008.01640.x 1:STN:280:DC%2BD2sjisVCksw%3D%3D 18053013
42. U. Wahn S.B. Dass 2008 Review of recent results of montelukast use as a monotherapy in children with mild asthma Clin Ther 30 1026 1035 10.1016/j.clinthera.2008.05.018 1:CAS:528:DC%2BD1cXhtValsrzE 18640477 (Pubitemid 351982027)
43. C.A. Sorkness R.F. Lemanske Jr. D.T. Mauger 2007 Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial J Allergy Clin Immunol 119 64 72 10.1016/j.jaci.2006.09.042 17140647 (Pubitemid 46043379)
44. T. Jartti 2008 Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma? Eur J Pediatr 167 731 736 10.1007/s00431-007-0644-3 1:CAS:528:DC%2BD1cXmtFehtLY%3D 18214538
45. R.C. Strunk L.B. Bacharier B.R. Phillips 2008 Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study J Allergy Clin Immunol 122 1138 1144 10.1016/j.jaci.2008.09.028 1:CAS:528:DC%2BD1cXhsV2ltr%2FO 18951618
46. A.B. Becker O. Kuznetsova J. Vermeulen 2006 Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study Ann Allergy Asthma Immunol 96 800 807 1:CAS:528:DC%2BD28XmvVKrs74%3D 16802767
47. S. Pedersen L. Agertoft D. Williams-Herman 2007 Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic children Pediatr Pulmonol 42 838 843 10.1002/ppul.20666 17659605 (Pubitemid 47580811)
48. K.A. Nelson S.R. Smith K. Trinkaus D.M. Jaffe 2008 Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years Pediatr Emerg Care 24 21 27 18165796
49. C.F. Robertson D. Price R. Henry 2007 Short-course montelukast for intermittent asthma in children: a randomized controlled trial Am J Respir Crit Care Med 175 323 329 10.1164/rccm.200510-1546OC 1:CAS:528:DC%2BD2sXjtlajs7k%3D 17110643 (Pubitemid 46271555)
50. N.W. Johnston P.J. Mandhane J. Dai 2007 Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy Pediatrics 120 e702 712 10.1542/peds.2006- 3317 17766511 (Pubitemid 47358285)
51. R.A. Covar S.J. Szefler R.S. Zeiger 2008 Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children J Allergy Clin Immunol 122 741 747 10.1016/j.jaci.2008.08.021 1:CAS:528:DC%2BD1cXht1Siu7jE 19014765
52. R.S. Zeiger S.J. Szefler B.R. Phillips 2006 Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma J Allergy Clin Immunol 117 45 52 10.1016/j.jaci.2005.10.012 1:CAS:528: DC%2BD28Xktlaj 16387583 (Pubitemid 43017138)
53. S.J. Szefler B.R. Phillips F.D. Martinez 2005 Characterization of within-subject responses to fluticasone and montelukast in childhood asthma J Allergy Clin Immunol 115 233 242 10.1016/j.jaci.2004.11.014 1:CAS:528: DC%2BD2MXhtVOntrg%3D 15696076 (Pubitemid 40215084)
54. F.M. de Benedictis M.M. del Giudice N. Forenza F. Decimo D. de Benedictis A. Capristo 2006 Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children Eur Respir J 28 291 295 10.1183/09031936.06.00020606 16641126 (Pubitemid 44914226)
55. P.L. Brand E. Baraldi H. Bisgaard 2008 Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach Eur Respir J 32 1096 1110 10.1183/09031936.00002108 1:STN:280:DC%2BD1cnjs1ensw%3D%3D 18827155
56. H. Bisgaard S. Zielen M.L. Garcia-Garcia 2005 Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma Am J Respir Crit Care Med 171 315 322 10.1164/rccm.200407-894OC 15542792 (Pubitemid 40223397)
57. L.B. Bacharier B.R. Phillips R.S. Zeiger 2008 Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing J Allergy Clin Immunol 122 1127 1135 10.1016/j.jaci.2008.09.029 1:CAS:528:DC%2BD1cXhsV2ltr%2FN 18973936
58. G.M. Davies E.J. Dasbach N.C. Santanello B.A. Knorr D.L. Bratton 2004 The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma Clin Ther 26 1895 1904 10.1016/j.clinthera.2004.11.010 1:CAS:528:DC%2BD2MXotFarug%3D%3D 15639701 (Pubitemid 40089502)
59. H. Bisgaard A. Flores-Nunez A. Goh 2008 Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children Am J Respir Crit Care Med 178 854 860 10.1164/rccm.200706-910OC 1:CAS:528:DC%2BD1cXhtlaisLfE 18583576
60. G.L. Kearns S. Lu L. Maganti 2008 Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis J Clin Pharmacol 48 502 511 10.1177/0091270008314251 1:CAS:528: DC%2BD1cXkslKntb4%3D 18296556
61. B. Knorr L. Maganti R. Ramakrishnan C.A. Tozzi E. Migoya G. Kearns 2006 Pharmacokinetics and safety of montelukast in children aged 3 to 6 months J Clin Pharmacol 46 620 627 10.1177/0091270006288324 1:CAS:528:DC%2BD28XlvVOqt74%3D 16707408 (Pubitemid 43920226)
62. P. Patel G. Philip W. Yang 2005 Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis Ann Allergy Asthma Immunol 95 551 557 16400895
63. G. Philip D. Williams-Herman P. Patel 2007 Efficacy of montelukast for treating perennial allergic rhinitis Allergy Asthma Proc 28 296 304 10.2500/aap.2007.28.3000 1:CAS:528:DC%2BD2sXot1Kqur0%3D 17619558
64. D.V. Wallace M.S. Dykewicz D.I. Bernstein 2008 The diagnosis and management of rhinitis: an updated practice parameter J Allergy Clin Immunol 122 suppl.2 1 84 10.1016/j.jaci.2008.06.003 (Pubitemid 352033573)
65. G.K. Scadding S.R. Durham R. Mirakian 2008 Clin Exp Allergy 38 19 42 10.1111/j.1365-2222.2008.03022.x 1:STN:280:DC%2BD2sjksFOqtw%3D%3D 18081563
66. Schünemann H, Brozek J, Bousquet J, et al. ARIA 2009 Revision. Allergy. In press.
67. J.L. Brozek C.E. Baena-Cagnani S. Bonini 2008 Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update Allergy 63 38 46 1:STN:280:DC%2BD2sjisVCksQ%3D%3D 18053015
68. J. Bousquet S. Gaugris V.S. Kocevar 2005 Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy Clin Exp Allergy 35 723 727 10.1111/j.1365-2222.2005. 02251.x 1:STN:280:DC%2BD2MzitFSlug%3D%3D 15969661 (Pubitemid 40961343)
69. J. Bousquet H.A. Boushey W.W. Busse 2004 Characteristics of patients with seasonal allergic rhinitis and concomitant asthma Clin Exp Allergy 34 897 903 10.1111/j.1365-2222.2004.01969.x 1:STN:280:DC%2BD2c3psFKntQ%3D%3D 15196277 (Pubitemid 38824067)
70. R. Dahl L.P. Nielsen J. Kips 2005 Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma Allergy 60 875 881 10.1111/j.1398-9995.2005.00819.x 1:CAS:528:DC%2BD2MXmtFGqsL8%3D 15932376 (Pubitemid 40813808)
71. C.E. Baena-Cagnani W.E. Berger L.M. DuBuske 2003 Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma Int Arch Allergy Immunol 130 307 313 10.1159/000070218 1:CAS:528:DC%2BD3sXjs1Giu78%3D 12740532 (Pubitemid 36570293)
72. G. Philip A.S. Nayak W.E. Berger 2004 The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis Curr Med Res Opin 20 1549 1558 10.1185/030079904X3348 1:CAS:528: DC%2BD2MXhtVGlsw%3D%3D 15462688 (Pubitemid 39457543)
73. W.W. Busse T.B. Casale M.S. Dykewicz 2006 Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aero-allergen sensitivity Ann Allergy Asthma Immunol 96 60 68 1:CAS:528:DC%2BD28XhtVOjur8%3D 16440534